Christopher S Ambrose

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Chronic Obstructive Pulmonary Disease

Systematic Review

Allergic Rhinitis

Top Venues

Journal of asthma and allergy

Advances in therapy

Health science reports

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Reynold A Panettieri, Njira L Lugogo, Jonathan Corren, Christopher S Ambrose
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types. Journal of asthma and allergy 17 (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Weily Soong, Bradley E Chipps, Warner Carr, Jennifer Trevor, Arpan Patel, Nicole Clarke, Donna D Carstens, Christopher S Ambrose
Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma. Journal of asthma and allergy 17 (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy (2024)
Weily Soong, Bradley E Chipps, Warner Carr, Jennifer Trevor, Arpan Patel, Nicole Clarke, Donna D Carstens, Christopher S Ambrose
Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma. Journal of asthma and allergy 17 (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Geoffrey L Chupp, Michael E Wechsler, Gillian Hunter, Andrew W Lindsley, Jean-Pierre Llanos, Luke K Burke, Shradha Chandarana, Christopher S Ambrose
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Advances in therapy 41 (7) (2024)
Reynold A Panettieri, Njira L Lugogo, Jonathan Corren, Christopher S Ambrose
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types. Journal of asthma and allergy 17 (2024)
Stephanie Korn, Bill Cook, Lisa J Simpson, Jean-Pierre Llanos, Christopher S Ambrose
Efficacy of Biologics in Severe, Uncontrolled Asthma Stratified by Blood Eosinophil Count: A Systematic Review. Advances in therapy (2023)
Joseph D Spahn, Christopher E Brightling, Paul M O'Byrne, Lisa J Simpson, Nestor A Molfino, Christopher S Ambrose, Neil Martin, Teal S Hallstrand
Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review. Journal of asthma and allergy 16 (2023)
Jonathan A Bernstein, Jean-Pierre Llanos, Gillian Hunter, Neil Martin, Christopher S Ambrose
Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review. Advances in therapy (2023)
Njira Lugogo, Bradley E Chipps, Reynold A Panettieri, Frank Trudo, Christopher S Ambrose
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma. Journal of asthma and allergy 15 (2022)
Njira Lugogo, Bradley E Chipps, Reynold A Panettieri, Frank Trudo, Christopher S Ambrose
Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma. Journal of asthma and allergy 15 (2022)
Wendy C Moore, Dennis K Ledford, Donna D Carstens, Christopher S Ambrose
Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study. Journal of asthma and allergy 15 (2022)
Andrew N Menzies-Gow, Claire McBrien, Bindhu Unni, Celeste M Porsbjerg, Mona Al Ahmad, Christopher S Ambrose, Karin Dahl Assing, Anna von Bülow, John Busby, Borja García Cosio, J Mark FitzGerald, Esther Garcia Gil, Susanne Hansen, Liam G aHeaney, Mark Hew, David J Jackson, Maria Kallieri, Stylianos Loukides, Njira L Lugogo, Andriana I Papaioannou, Désirée Erlinda Larenas-Linnemann, Wendy C Moore, Luis A Perez-de-Llano, Linda M Rasmussen, Johannes M Schmid, Salman Siddiqui, Marianna Alacqua, Trung N Tran, Charlotte Suppli Ulrik, John W Upham, Eileen Wang, Lakmini Bulathsinhala, Victoria A Carter, Isha Chaudhry, Neva Eleangovan, Ruth B Murray, Chris A Price, David J Price
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study. Journal of asthma and allergy 15 (2022)
Weily Soong, Bradley E Chipps, Sean O'Quinn, Jennifer Trevor, Warner W Carr, Laura Belton, Frank Trudo, Christopher S Ambrose
Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma. Journal of asthma and allergy 14 (2021)
Gail M Gauvreau, Roma Sehmi, Christopher S Ambrose, Janet M Griffiths
Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert opinion on therapeutic targets 24 (8) (2020)
Christopher S Ambrose, Bradley E Chipps, Wendy C Moore, Weily Soong, Jennifer Trevor, Dennis K Ledford, Warner W Carr, Njira Lugogo, Frank Trudo, Trung N Tran, Reynold A Panettieri
The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results. Pragmatic and observational research 11 (2020)
Christopher S Ambrose
Is it RSV? Health science reports 1 (12) (2018)